Transdermal Delivery Solutions Corp

This study tests a new way to deliver insulin for type 2 diabetes: a spray applied to the skin instead of an injection. Thirty adults who already use insulin will try the spray for 21 days. Researchers will check if it keeps blood sugar in a safe range and causes less skin irrita…

This phase 2 trial tests a new testosterone spray (HypoSpray) in 48 men with low testosterone. Participants receive one of four doses daily for 7 days. The goal is to measure how testosterone levels change and check for skin reactions. Results will guide future, longer studies.

This study looks at whether a testosterone lotion applied to men's skin can transfer to women through casual contact. Researchers will measure testosterone levels in the blood of female partners after skin-to-skin contact. The goal is to understand if the lotion is safe for use a…